Prerpints.org logo
Preprint
Article

Dietary Sodium and Potassium Intakes and Prevalent Kidney Stone: The National Health and Nutrition Examination Survey 2011-2018

Altmetrics

Downloads

143

Views

45

Comments

0

A peer-reviewed article of this preprint also exists.

supplementary.docx (97.66KB )

This version is not peer-reviewed

Submitted:

24 June 2024

Posted:

25 June 2024

You are already at the latest version

Alerts
Abstract
The associations between dietary sodium intake (DSI), dietary potassium intake (DPI), and kidney stone disease (KSD) are not clear. We examined The National Health and Nutrition Examination Survey 2011-2018 to determine the independent associations between daily DSI, DPI, DSI/DPI and prevalent KSD. 19,405 participants were included for analysis, of which 1,895 had KSD. Higher DSI was not associated with increased odds of KSD in regression analysis when DSI was modeled as a continuous variable (OR=0.99, 95% CI: 0.99-1.00, p=0.2), or when comparing highest quartile of DSI to lowest quartile (OR=0.84, 95% CI: 0.68–1.04, p=0.1). Unlike DSI, higher DPI associated strongly with reduced odds of KSD in regression analysis when DPI was modeled as a continuous variable (OR=0.99, 95% CI: 0.99-0.99, p=0.02), or when comparing highest quartile of DPI to lowest quartile (OR =0.75, 95% CI: 0.60–0.94, p=0.01). Lastly, higher DSI/DPI also associated strongly with increased odds of KSD in regression analysis when DSI/DPI was modeled as a continuous variable (OR=1.1, 95% CI: 1.01-1.20, p=0.03), or when comparing highest quartile of DPI to lowest quartile (OR =1.30, 95% CI: 1.10–1.70, p=0.008). All the observed relationships were independent of total calorie intake. In conclusion, both lower DPI and higher DSI/DPI associate with an increased risk of KSD. Future prospective studies are needed to clarify these causal relationships.
Keywords: 
Subject: Medicine and Pharmacology  -   Dietetics and Nutrition

1. Introduction

Kidney stone disease (KSD) is common in the US population with an estimated prevalence of around 10-15% in males and 3–5% in females [1]. It causes significant morbidities and has a huge economic impact on our healthcare system [2]. Kidney stone formation is a complex process with diet playing a crucial role.
Since the vast majority (~80%) of kidney stones are calcium-based, hypercalciuria is considered a major risk factor for kidney stone formation [3]. In healthy volunteers, dietary sodium intake (DSI) has a direct effect on urinary calcium excretion [4,5]. However, its role in promoting kidney stone is far from being established. A large population study showed a strong association between DSI and the risk of incident kidney stone disease [6]. However, this association cannot be corroborated by other similar population studies [7,8,9]. This inconsistency may reflect the differences in population surveyed and hidden confounders. Unlike dietary sodium, high dietary potassium intake (DPI) was thought to reduce stone risk due to its association with lower urinary calcium excretion [10]. However, results from observational studies have been also conflicting, and there is a lack of interventional trials[7,8,11,12]. Lastly, the balance between dietary sodium and potassium intakes may also be important in modifying kidney stone risk since both are key determinants of urinary calcium excretion. Unfortunately, to date, the combined effect of DSI and DKI on stone risk remains to be elucidated. Better understanding of these knowledge gaps could guide effective dietary interventions to reduce the burden of KSD. Therefore, in this study of the US adults from the National Health and Nutrition Examination Survey (NHANES) 2011-2018, we aim to examine the independent associations of DSI, DPI and DSI/DPI on the risk of prevalent KSD.

2. Materials and Methods

2.1. Study Population

The National Health and Nutrition Examination Survey is a national probability sample of the total non-institutionalized civilian population 2 months of age or over in the USA. The survey collected demographic, socioeconomic, dietary and health-related information, in addition to the examination and laboratory data obtained by highly trained medical personnel. There were a total of 39,157 participants in NHANES 2011-2018, and our analyses were limited to 23,826 adult participants of 18 years or older. The information regarding prevalent kidney stone disease was extracted from the interview data file. ‘Have you ever had a kidney stone?’ was the question asked during the standardized home interview. The adult participants who responded ‘yes’ to the question were considered to have a history of kidney stones. Responders who did not complete at least 1 dietary recall, had erroneous dietary intake data (DSI>10,000mg), had missing body mass index (BMI), had incomplete data on the history of hypertension, diabetes and diuretics use were excluded (n = 4,421). Thus, the final sample used in this study included 19,405 adult participants (Figure 1). Among them, 1,895 had self-reported history of kidney stones.

2.2. Primary Predictors and Outcomes

The primary predictor or independent variables were DSI, DPI, and the ratio of DSI/DPI. In the NHANES, 24-hour recall queried all foods/beverages consumed from midnight-to-midnight on the day before the interview. Related nutrient data were obtained from the USDA’s Food and Nutrient Database for Dietary Studies. Mean intake of sodium (mg/day) and potassium (mg/day) were estimated based on dietary recalls in each survey period. The recommended sodium intake was defined as DSI <2,300 mg/day based on the published Dietary Guidelines for Americans 2015–2020 [13]. Optimal DPI recommended by organizations like World Health Organization was defined at ≥3,500 mg per day [14].
The outcome or dependent variable of interest was prevalent KSD. It was extracted from the interview data file. ‘Have you ever had a kidney stone?’ was the question asked during the standardized home interview. Adult participants who responded ‘yes’ to the question were considered to have a history of kidney stone.

2.3. Covariates

Age was defined as age at the time of the interview. Race/ethnicity was self-reported. The history of hypertension was defined as self-reported physician diagnosis of hypertension, or use of any antihypertensives, or if they had mean blood pressure (BP) measurements showing a systolic BP ≥140 mm Hg and/or a diastolic BP ≥90 mm Hg. The history of diabetes was defined as self-reported physician diagnosis of diabetes or taking hypoglycemics. The history of dyslipidemia was defined as self-reported physician diagnosis of hypercholesterolemia or taking medications to lower blood cholesterol. A history of cardiovascular disease (CVD) was defined as self-reported physician diagnosis of heart failure, coronary heart disease, angina, heart attack or stroke, or having had coronary revascularization. BMI was calculated from the weight and height measured during the physical examination. Hydrochlorothiazide (HCTZ) use was documented during the standardized home interview. Information on cigarette smoking was also collected during the interview. Frequency of alcohol consumption was measured by a food frequency questionnaire. Alcohol consumption (in grams/day) was also evaluated with a 24-hour dietary recall and categorized into tertiles of consumption for the purposes of our analysis.

2.4. Data Analysis and Statistical Methods

To be included in the study, participants had to have data on kidney stones, dietary sodium, potassium, and total calorie intakes, age, sex, race, BMI, information regarding thiazide diuretic use, whether or not having a history of hypertension, diabetes and dyslipidemia. The results of continuous variables were expressed as the mean ± standard deviation for normal distributions and as the median for skewed distributions. Categorical variables are expressed as frequencies and percentages. Due to the complex sample strategy of NHANES, appropriate weights and strata were applied. STATA (11.2) PROC SVY:TAB and SVY: MEANS were used to obtain descriptive statistics for the population. Characteristics of the population were compared between stone formers and non-stone formers using the Rao-Scott 2 for the categorical variables and ANOVA for the continuous variables. STATA (11.2) SVY LOGISTIC was used to perform logistic regression to determine if DSI, DPI, DSI/DPI were associated with a history of kidney stones. Two logistic regression models controlling potential confounders were used to assess the associations in the overall sample. Results are presented as odds ratio (OR) and 95% confidence interval (CI)

2.5. Ethical Considerations

Ethical issues were addressed in accordance with the guidelines of the Declaration of Helsinki.

3. Results

3.1. Baseline Characteristics

There were a total of 19,405 participants eligible for the final analysis, including 1895 who reported a history of kidney stone. Among stone formers, mean DSI was 3438mg with only 26% had DSI less than 2300mg. Mean DPI was 2572mg with 19% had DPI ≥3500mg. Mean DSI/DPI was 1.5. In comparison, among non-stone formers, mean DSI was 3532mg (p=0.1) with 24% had DSI less than 2300mg (p=0.2), mean DPI was 2665mg (p=0.03) with 21% had DPI ≥3500mg (p=0.2), DSI/DPI was 1.4 (p=0.2). As shown in Table 1, stone formers tended to be older, to be males and non-Hispanic whites, and to have a higher BMI compared to non-stone formers. They were also more likely to have prevalent hypertension, diabetes, dyslipidemia, cardiovascular disease and take thiazide diuretics, more likely to be an active smoker and heavy drinker.
When we break down DSI, DPI, and DSI/DPI into quartiles, participants in the highest quartile of DSI were more likely to be younger, to be male and non-Hispanic whites, to have a higher BMI, to have lower prevalence of hypertension, dyslipidemia and cardiovascular disease, and less likely to be an active smoker and to drink alcohol heavily than participants in the lower quartiles of DSI (Table 2). Participants in the highest quartile of DPI were more likely to be older, to be male and non-Hispanic whites, to have a lower BMI, to have dyslipidemia, but less likely to have a history of diabetes or cardiovascular disease, to be an active smoker and to drink heavily than participants in the lower quartiles of DPI (Table 3). With regard to DSI/DPI, participants in the highest quartiles were more likely to be younger, to be male, to have a higher BMI, to be an active smoker, to drink alcohol heavily, but less likely to be non-Hispanic whites, to have histories of hypertension, dyslipidemia, or cardiovascular disease (Table 4).

3.2. Dietary Sodium and Potassium Intakes and Prevalent Kidney Stone

The logistic regression analyses examining the relationships between DSI, DPI, DSI/DPI and kidney stone disease are shown in Table 5 and Table 6. Higher sodium intake was not associated with increased odds of kidney stone disease in univariate analysis (OR=0.99, 95% CI: 0.99-1.00, p=0.1), and in regression analysis when DSI was modeled as a continuous variable after adjustment for age, sex, race, BMI, histories of hypertension, diabetes, dyslipidemia, cardiovascular disease, usage of HCTZ, cigarette smoking and alcohol drinking (OR=0.99, 95% CI: 0.99-1.00, p=0.2). When kidney stone risk was examined with extreme categories of DSI or by binary comparison of DSI, the multivariate-adjusted OR for stone formation was 0.84 (95% CI: 0.68–1.04, p = 0.1) in those who consumed >4321 mg/day DSI compared to those with < 2227 mg/day of DSI, and the OR was 1.10 (95% CI: 0.93-1.20, p=0.3) in those who consumed ≤2300 mg DSI compared to those with >2300 mg DSI (Table 5). When we adjusted for dietary calorie intake using DSI/DCI as the predictor variable, the findings were similar (Supplemental Table S1). Unlike DSI, higher DPI associated with reduced odds of kidney stone disease in both univariate analysis (OR=0.99, 95% CI: 0.99-0.99, p=0.04) and in regression analysis after adjustment for age, sex, race, BMI, histories of hypertension, diabetes, dyslipidemia, cardiovascular disease, usage of HCTZ, cigarette smoking and alcohol drinking when DPI was modeled as a continuous variable (OR=0.99, 95% CI: 0.99-0.99, p=0.02). When we examined the extreme categories of DPI, there was a 25% reduction in stone risk (multivariate-adjusted OR =0.75, 95% CI: 0.60–0.94, p = 0.01) in those who consumed >3209 mg/day DPI compared to those with <1699 mg/day of DPI (Table 5). When we adjusted DCI using DPI/DCI as the predictor variable, the findings were also similar (Supplemental Table S1). Lastly, when we examined the combined effect of DSI and DPI reflected by DSI/DPI, higher DSI/DPI associated with increased odds of kidney stone disease in both univariate analysis (OR=1.2, 95% CI: 1.10-1.20, p=0.04) and in regression analysis after adjustment for age, sex, race, BMI, histories of hypertension, diabetes, dyslipidemia, cardiovascular disease, usage of HCTZ, cigarette smoking and alcohol drinking when DSI/DPI was modeled as a continuous variable (OR=1.1, 95% CI: 1.01-1.20, p=0.03). When we examined the extreme categories of DSI/DPI, there was a 30% increase in stone risk (multivariate-adjusted OR =1.30, 95% CI: 1.10–1.70, p = 0.008) when quartile 4 was compared to quartile 1, with a gradient effect observed in quartile comparisons (Table 5).
There were no interaction effects of dietary intake X other covariates in the regression model on kidney stone formation. In our multivariate logistic regression analyses, the following variables were found to have significant associations with increased odds of prevalent kidney stone disease: older age, male sex, non-Hispanic white, increasing BMI, history of hypertension, diabetes and dyslipidemia, active cigarette smoking and heavy alcohol use (Table 6).

4. Discussion

In this large US population based cross-sectional study, we showed that DSI did not associate with an increased risk of prevalent kidney stone. But lower DPI and higher DSI/DPI significantly increased the risk of prevalent kidney stones. The results of this large population study highlights the significance of DPI in kidney stone management. To our knowledge, this is the first study examining the combinational effect of DSI and DPI on the risk of kidney stone disease.
Both sodium and potassium are key nutrients essential for maintenance of body fluid volume, acid and electrolyte balance, and normal cellular function. In modern society, dietary sodium and potassium content have been markedly altered. Food processing increases the sodium and reduces the potassium content of food [15]. As a result, most adult populations worldwide have mean sodium intakes above 2300mg per day [16], and potassium intakes below 3500 mg per day [17]. Higher DSI is directly associated with hypercalciuria, a major risk factor for KSD. The association between DSI and urinary calcium excretion was first observed in an animal model by Walser et al. [18], and was later confirmed in human studies [19,20,21]. This correlation between urine sodium and calcium remained significant even during fasting, and dietary salt restriction lowered urine calcium excretion further proving a causal relationship [22]. Given that hypercalciuria is a strong risk factor for kidney stone disease, it is only natural to assume that dietary salt restriction would be beneficial for stone prevention. However, large population studies showed conflicting data on the association between DSI and incident kidney stone risk [6,7,8,9]. These discrepancies may reflect the difficulties in obtaining reliable estimates of dietary salt intake and the presence of many hidden confounders. In this study of a large nationally representative sample of the US population, we also failed to show a significant association between DSI and prevalent kidney stone, regardless of DSI being analyzed as a continuous or as a categorical variable. To account for variations in calorie consumption, we also used DSI/DCI (dietary sodium density) as a predictor variable, a measure that has been well validated in clinical trials [23]. Again, we did not show any association of sodium-dense diet on prevalent kidney stone regardless of the analytical approaches. We believe our results are consistent that higher DSI does not increase the risk of kidney stone formation. Although not proven, it is conceivable that higher DSI promotes oral hydration, therefore offsets its harmful effect of raising urine calcium excretion. Indeed, a retrospective analysis of 880 kidney stone formers revealed that higher urine sodium led to an increase in urine calcium, but more importantly also a large increase in urine volume, resulting in a significant reduction in calcium oxalate supersaturation in the urine [24].
Contrary to sodium, adequate body potassium store is essential for the renal tubular reabsorption of calcium, therefore can reduce urinary calcium excretion. DPI has been shown to modulate sodium-chloride cotransporter channel activity via basolateral Kir4.1 at the distal convoluted tubule [25]. As a result, higher DPI can decrease urinary calcium excretion by inducing transient sodium diuresis, which results in a temporary contraction of the extracellular fluid volume and an increase in renal tubular calcium reabsorption. Furthermore, potassium increases renal phosphate reabsorption and reduces vitamin D due to phosphate retention, resulting in decreased intestinal calcium absorption and subsequent urinary calcium excretion [26]. Indeed, a human study did confirm the inverse relationship between urinary potassium and calcium excretions [27]. An interventional study further demonstrated that potassium administration reduces and potassium deprivation increases urinary calcium excretion in healthy adults [10]. Lastly, potassium reduces the expression of Na+-dicarboxylate cotransporter 1, a key protein involved in renal citrate reabsorption [28]. In a cohort of recurrent calcium kidney stone formers, urine potassium had a strong positive correlation with urine citrate level, and dietary potassium chloride supplementation resulted in a significant increase in urinary citrate excretion [29]. Therefore, inadequate DPI can stimulate renal tubular citrate reabsorption resulting in hypocitraturia, another major risk factor for calcium stone formation [30]. To demonstrate a direct effect of DKI on the overall stone risk, we showed a strong independent effect of DKI on the risk of prevalent kidney stone in this large US population cohort. This effect remained strongly significant after we adjusted DCI using DKI/DCI as the predictor variable. Our finding is consistent with another large population study which revealed a significantly lowered urinary potassium excretion among incidence kidney stone formers, indicating an important role of DPI in kidney stone formation [31].
In addition to their individual effects, the combined activity of dietary sodium and potassium worth investigating as recent clinical studies suggested that DSI/DPI ratio was more predictive of clinical outcomes (i.e., hypertension, cardiovascular disease event) than either DSI or SPI alone [32,33]. Urine sodium/potassium ratio also appears to associate more strongly with urinary calcium excretion than either urine sodium or potassium alone [27], indicating an additive or even synergistic effect of high DSI plus low DPI in promoting hypercalciuria. Indeed, we found that higher DSI/DPI ratio strongly associated with the prevalent kidney disease, an effect much stronger than either the DSI or DPI alone. This finding is novel, because for the first time it provided direct evidence that dietary salt restriction combined with an increased DPI could be more effective for kidney stone prevention.
Our study has limitations worth noting. First, as a cross-sectional study, the present analysis is limited in its ability to establish causal or temporal relationships between dietary sodium and potassium intakes and kidney stone formation. Second, our dietary estimates excluded sodium from table salt, supplements, and medications, which account for an estimated 6% of total dietary sodium intake [34], thus underestimating the proportion of participants with excessive intakes. We also excluded potassium from salt substitute, supplements and medications. Although it is possible that stone formers in this cohort were following a low sodium diet after the publication of a AUA guideline in 2014 recommending dietary salt restriction for patients with KSD [35], when we examined dietary intakes before and after 2014, no change in DSI was found among stone formers in this large US population cohort (Supplemental Table S2). It is also unlikely that stone formers would increase DPI or taking potassium supplement for secondary stone prevention since there is a lack of clinical evidence so far to support such practice. However, the potential confounding from the use of potassium citrate, a medication commonly prescribed for KSD, needs to be considered. Unfortunately, the information regarding such medication use is lacking in NHANES. Third, the prevalent kidney stone cases were self-reported, and some participants may have kidney stone disease without self-awareness or clinical diagnosis. This may have led to potential misclassification, but should be non-selective with regard to different dietary intake. Furthermore, if this misclassification exists, the results should be biased toward null. Finally, we do not have information on stone composition, although 80% of kidney stones in the general population like NHANES are calcium based.

5. Conclusions

In summary, although DSI by itself was not a strong predictor of prevalent kidney stone, higher DSI combined with lower DPI did has a strong association with kidney stone risk. Regardless of DSI, lower DPI strongly associated with an increased odd of prevalent kidney stone disease.
The rising kidney stone prevalence world-wide showcases the failure to implement effective interventions in the management of KSD, calling for more effective public health policy to reduce the disease burden on a population level. Public health interventions aimed at reducing DSI and increasing DPI are, therefore, potential cost effective measures for reducing the burden of KSD.

Supplementary Materials

The following supporting information can be downloaded at the website of this paper posted on Preprints.org

Author Contributions

Conceptualization, JT and MC; Methodology, JT and CS; Software, CS; Validation, JT, CS and MC; Formal Analysis, CS; Investigation, JT, CS and MC; Resources, JT and MC; Data Curation, CS; Writing—Original Draft Preparation, JT; Writing—Review & Editing, JT, CS and MC; Supervision, MC; Project Administration, JT; Funding Acquisition, JT and MC. All the authors reviewed this final submitted manuscript and agreed with its contents.

Funding

This work is supported by a Brown Physicians Inc Foundation Grant (JT).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of Lifespan Hospitals, Providence, RI (protocol code 966236-3, date of approval 10/20/2016).

Informed Consent Statement

Not applicable.

Data Availability Statement

Records and data pertaining to this study are stored electronically at the Division of Kidney Diseases and Hypertension, Alpert Medical School of Brown University in Providence, USA, and can be provided by the corresponding author on a reasonable request.

Acknowledgments

Not applicable.

Conflicts of Interest

None of the authors declare a competing interest, and the results presented in this paper have not been published previously in whole or part, except in abstract format.

References

  1. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63(5):1817-1823. [CrossRef]
  2. Saigal CS, Joyce G, Timilsina AR, Urologic Diseases in America P. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int. 2005;68(4):1808-1814. [CrossRef]
  3. Finkielstein, V.A.; Goldfarb, D.S. Strategies for preventing calcium oxalate stones. Can. Med Assoc. J. 2006, 174, 1407–1409. [CrossRef]
  4. Sakhaee, K.; Harvey, J.A.; Padalino, P.K.; Whitson, P.; Pak, C.Y. The Potential Role of Salt Abuse on the Risk for Kidney Stone Formation. J. Urol. 1993, 150, 310–312. [CrossRef]
  5. Taylor, E.N.; Curhan, G.C. Demographic, Dietary, and Urinary Factors and 24-h Urinary Calcium Excretion. Clin. J. Am. Soc. Nephrol. 2009, 4, 1980–1987. [CrossRef]
  6. Sorensen, M.D.; Kahn, A.J.; Reiner, A.P.; Tseng, T.Y.; Shikany, J.M.; Wallace, R.B.; Chi, T.; Wactawski-Wende, J.; Jackson, R.D.; O’Sullivan, M.J.; et al. Impact of Nutritional Factors on Incident Kidney Stone Formation: A Report From the WHI OS. J. Urol. 2012, 187, 1645–1650. [CrossRef]
  7. Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women: Nurses’ Health Study II. Arch Intern Med. 2004;164(8):885-891. [CrossRef]
  8. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol. 2004;15(12):3225-3232. [CrossRef]
  9. Curhan, G.C.; Willett, W.C.; Rimm, E.B.; Stampfer, M.J. A Prospective Study of Dietary Calcium and Other Nutrients and the Risk of Symptomatic Kidney Stones. N. Engl. J. Med. 1993, 328, 833–838. [CrossRef]
  10. Lemann J, Jr., Pleuss JA, Gray RW, Hoffmann RG. Potassium administration reduces and potassium deprivation increases urinary calcium excretion in healthy adults [corrected]. Kidney Int. 1991;39(5):973-983. [CrossRef]
  11. Curhan, G.C.; Speizer, F.E.; Spiegelman, D.; Stampfer, M.J. Comparison of Dietary Calcium with Supplemental Calcium and Other Nutrients as Factors Affecting the Risk for Kidney Stones in Women. Ann. Intern. Med. 1997, 126, 497–504. [CrossRef]
  12. Ferraro PM, Mandel EI, Curhan GC, Gambaro G, Taylor EN. Dietary Protein and Potassium, Diet-Dependent Net Acid Load, and Risk of Incident Kidney Stones. Clin J Am Soc Nephrol. 2016;11(10):1834-1844. [CrossRef]
  13. US Department of Health and Human Services. 2015–2020 Dietary Guidelines for Americans. US Department of Health and Human Services: Washington, DC, 2015, p. 144.
  14. Weaver CM, Stone MS, Lobene AJ, Cladis DP, Hodges JK. What Is the Evidence Base for a Potassium Requirement? Nutr Today. 2018;53(5):184-195. [CrossRef]
  15. Medicine Io. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. National Academies Press. 2005.
  16. Brown, I.J.; Tzoulaki, I.; Candeias, V.; Elliott, P. Salt intakes around the world: implications for public health. Int. J. Epidemiol. 2009, 38, 791-813. [CrossRef]
  17. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ. 1988;297(6644):319-328.
  18. Walser, M. Calcium clearance as a function of sodium clearance in the dog. Am. J. Physiol. Content 1961, 200, 1099–1104. [CrossRef]
  19. Muldowney, F.P.; Freaney, R.; Moloney, M.F. Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int. 1982, 22, 292–296. [CrossRef]
  20. Kleeman, C.R.; Bohannan, J.; Bernstein, D.; Ling, S.; Maxwell, M.H. Effect of Variations in Sodium Intake on Calcium Excretion in Normal Humans.. Exp. Biol. Med. 1964, 115, 29–32. [CrossRef]
  21. Shortt, C.; Madden, A.; Flynn, A.; A Morrissey, P. Influence of dietary sodium intake on urinary calcium excretion in selected Irish individuals. Eur J Clin Nutr. 1988, 42, 595–603.
  22. Nordin, B.E.C.; Need, A.G.; A Morris, H.; Horowitz, M. The Nature and Significance of the Relationship between Urinary Sodium and Urinary Calcium in Women. J. Nutr. 1993, 123, 1615–1622. [CrossRef]
  23. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344(1):3-10. [CrossRef]
  24. Eisner, B.H.; Eisenberg, M.L.; Stoller, M.L. Impact of Urine Sodium on Urine Risk Factors for Calcium Oxalate Nephrolithiasis. J. Urol. 2009, 182, 2330–2333. [CrossRef]
  25. Wang, M.-X.; Cuevas, C.A.; Su, X.-T.; Wu, P.; Gao, Z.-X.; Lin, D.-H.; McCormick, J.A.; Yang, C.-L.; Wang, W.-H.; Ellison, D.H. Potassium intake modulates the thiazide-sensitive sodium-chloride cotransporter (NCC) activity via the Kir4.1 potassium channel. Kidney Int. 2018, 93, 893–902. [CrossRef]
  26. Sebastian, A.; Hernandez, R.E.; Portale, A.A.; Colman, J.; Tatsuno, J.; Morris, R.C. Dietary potassium influences kidney maintenance of serum phosphorus concentration. Kidney Int. 1990, 37, 1341–1349. [CrossRef]
  27. Osorio, A.V.; Alon, U.S. The Relationship Between Urinary Calcium, Sodium, and Potassium Excretion and the Role of Potassium in Treating Idiopathic Hypercalciuria. 1997, 100, 675–681. [CrossRef]
  28. Osis, G.; Webster, K.L.; Harris, A.N.; Lee, H.-W.; Chen, C.; Fang, L.; Romero, M.F.; Khattri, R.B.; Merritt, M.E.; Verlander, J.W.; et al. Regulation of renal NaDC1 expression and citrate excretion by NBCe1-A. Am. J. Physiol. Physiol. 2019, 317, F489–F501. [CrossRef]
  29. Domrongkitchaiporn, S.; Stitchantrakul, W.; Kochakarn, W. Causes of Hypocitraturia in Recurrent Calcium Stone Formers: Focusing on Urinary Potassium Excretion. Am. J. Kidney Dis. 2006, 48, 546–554. [CrossRef]
  30. Zuckerman, J.M.; Assimos, D.G. Hypocitraturia: pathophysiology and medical management. Rev Urol. 2009, 11, 134–44.
  31. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int. 2001;59(6):2290-2298. [CrossRef]
  32. Stamler, J.; Rose, G.; Stamler, R.; Elliott, P.; Dyer, A.; Marmot, M. INTERSALT study findings. Public health and medical care implications.. Hypertension 1989, 14, 570–577. [CrossRef]
  33. Cook NR, Obarzanek E, Cutler JA, et al. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med. 2009;169(1):32-40. [CrossRef]
  34. Mattes, R.D.; Donnelly, D. Relative contributions of dietary sodium sources. J. Am. Coll. Nutr. 1991, 10, 383–393. [CrossRef]
  35. Pearle, M.S.; Goldfarb, D.S.; Assimos, D.G.; Curhan, G.; Denu-Ciocca, C.J.; Matlaga, B.R.; Monga, M.; Penniston, K.L.; Preminger, G.M.; Turk, T.M.; et al. Medical Management of Kidney Stones: AUA Guideline. J. Urol. 2014, 192, 316–324. [CrossRef]
Preprints 110223 g001
Figure 1. Schematic overview of participant selection and disposition.
Figure 1. Schematic overview of participant selection and disposition.
Preprints 110223 g001
Table 1. Basic characteristics of the study population.
Table 1. Basic characteristics of the study population.
Stone Former Non-Stone Former P Value
Total number 1895 17510
Age (years) 54 (± 0.4) 47 (± 0.3) <0.001
Sex (male %) 985 (52) 8230 (47) 0.01
Race (Non-Hispanic White %) 1421 (75) 11382 (65) <0.001
BMI (mg/m2) 30.9 (± 0.2) 29.2 (± 0.1) <0.001
History of hypertension (%) 910 (48) 5603 (32) <0.001
History of diabetes (%) 360 (19) 1576 (9) <0.001
History of dyslipidemia (%) 872 (46) 5778 (33) <0.001
Cardiovascular disease (%) 284 (15) 1401 (8) <0.001
Thiazide use (%) 208 (11) 1226 (7) <0.001
Smoking (%) Everyday/some day 379 (20) 3152 (18) <0.001
Past smoker 569 (30) 4202 (24)
Not at all 948 (50) 10156 (58)
Alcohol (%) Heavy 38 (2) 1051 (6) 0.001
Light 360 (19) 3852 (22)
None 1477 (78) 12607 (72)
DSI Mean (mg) 3438 (± 56) 3532 (± 17) 0.1
<2300mg/d (%) 493 (26) 4202 (24) 0.2
DPI Mean (mg) 2572 (± 43) 2665 (± 17) 0.03
≥3500 mg/d (%) 360 (19) 3677 (21) 0.2
DSI/DPI 1.5 (± 0.03) 1.4 (± 0.01) 0.2
Values are expressed as means (± SE) or numbers (%). Abbreviations: BMI, body mass index. DSI, dietary sodium intake. DKI, dietary potassium intake.
Table 2. Quartiles of DSI in the whole NHANES 2011-2018 cohort.
Table 2. Quartiles of DSI in the whole NHANES 2011-2018 cohort.
DSI (mg/day) P Value
0 - 2226 2227 - 3149 3150 - 4321 >4321
Age (years) 50 (± 0.4) 49 (± 0.4) 47 (± 0.4) 43 (± 0.4) <0.0001
Sex (male %) 1538 (30) 1999 (39) 2566 (50) 3634 (71) <0.0001
Race (Non-Hispanic White %) 3230 (63) 3434 (67) 3438 (67) 3327 (65) 0.0003
BMI (kg/m2) 28.8 (± 0.2) 29.1 (± 0.2) 29.2 (± 0.2) 29.8 (± 0.2) <0.0001
History of hypertension (%) 1846 (36) 1691 (33) 1642 (32) 1638 (32) 0.0003
History of diabetes (%) 564 (11) 564 (11) 462 (9) 461 (9) 0.1
History of dyslipidemia (%) 1794 (35) 1794 (35) 1642 (32) 1587 (31) 0.01
Cardiovascular disease (%) 564 (11) 513 (10) 411 (8) 307 (6) <0.0001
Thiazide use (%) 410 (8) 410 (8) 359 (7) 358 (7) 0.3
Smoking (%) Active 1025 (20) 820 (16) 872 (17) 972 (19) <0.0001
Past smoker 1128 (22) 1230 (24) 1334 (26) 1280 (25)
Not at all 2974 (58) 3024 (59) 2925 (57) 2866 (56)
Alcohol (%) Heavy 3999 (78) 3844 (75) 3695 (72) 3634 (71) <0.0001
Light 974 (19) 1128 (22) 1180 (23) 1126 (22)
None 154 (3) 154 (3) 257 (5) 205 (4)
Values are expressed as means (± SE) or numbers (%). Abbreviations: BMI, body mass index. DSI, dietary sodium intake.
Table 3. Quartiles of DPI in the whole NHANES 2011-2018 cohort.
Table 3. Quartiles of DPI in the whole NHANES 2011-2018 cohort.
DPI (mg/day) P Value
0-1698 1699-2374 2375-3209 >3209
Age (years) 45 (± 0.5) 47 (± 0.5) 48 (± 0.4) 48 (± 0.4) 0.0003
Sex (male %) 1693 (33) 2049 (40) 2462 (48) 3481 (68) <0.0001
Race (Non-Hispanic White %) 3027 (59) 3278 (64) 3540 (69) 3532 (69) <0.0001
BMI (kg/m2) 29.8 (± 0.2) 29.2 (± 0.2) 29.3 (± 0.2) 28.7 (± 0.2) 0.0001
History of hypertension (%) 1744 (34) 1741 (34) 1693 (33) 1638 (32) 0.6
History of diabetes (%) 616 (12) 512 (10) 513 (10) 461 (9) 0.0006
History of dyslipidemia (%) 1539 (30) 1741 (34) 1744 (34) 1792 (35) 0.0002
Cardiovascular disease (%) 564 (11) 461 (9) 410 (8) 410 (8) 0.0002
Thiazide use (%) 359 (7) 410 (8) 410 (8) 358 (7) 0.4
Smoking (%) Active 1180 (23) 973 (19) 821 (16) 870 (17) <0.0001
Past smoker 975 (19) 1127 (22) 1334 (26) 1485 (29)
Not at all 2975 (58) 3022 (59) 2975 (58) 3020 (59)
Alcohol (%) Heavy 4258 (83) 3893 (76) 3642 (71) 3532 (69) <0.0001
Light 770 (15) 1076 (21) 1283 (25) 1229 (24)
None 103 (2) 154 (3) 205 (4) 870 (17)
Values are expressed as means (± SE) or numbers (%). Abbreviations: BMI, body mass index. DKI, dietary potassium intake.
Table 4. Quartiles of DSI/DPI in the whole NHANES 2011-2018 cohort.
Table 4. Quartiles of DSI/DPI in the whole NHANES 2011-2018 cohort.
DSI/DPI P Value
<1.01 1.01-1.35 1.35-1.77 >1.77
Age (years) 52 (± 0.4) 49 (± 0.4) 46 (± 0.4) 41 (± 0.4) <0.0001
Sex (male %) 2181 (43) 2477 (48) 2553 (50) 2686 (52) <0.0001
Race (Non-Hispanic White %) 3500 (69) 3457 (67) 3369 (66) 3100 (60) <0.0001
BMI (kg/m2) 28.1 (± 0.2) 28.9 (± 0.2) 29.8 (± 0.2) 30.2 (± 0.2) <0.0001
History of hypertension (%) 1724 (34) 1754 (34) 1736 (34) 1601 (31) 0.05
History of diabetes (%) 507 (10) 568 (11) 511 (10) 517 (10) 0.6
History of dyslipidemia (%) 1877 (37) 1858 (36) 1685 (33) 1395 (27) <0.0001
Cardiovascular disease (%) 558 (11) 464 (9) 408 (8) 362 (7) 0.001
Thiazide use (%) 406 (8) 413 (8) 408 (8) 362 (7) 0.6
Smoking (%) Active 862 (17) 826 (16) 919 (18) 1137 (22) <0.0001
Past smoker 1319 (26) 1393 (27) 1225 (24) 1033 (20)
Not at all 2891 (57) 2941 (57) 2961 (58) 2996 (58)
Alcohol (%) Heavy 3601 (71) 3767 (73) 3727 (73) 4081 (79) <0.0001
Light 1217 (24) 1135 (22) 1123 (22) 930 (18)
None 254 (5) 258 (5) 204 (4) 207 (4)
Values are expressed as means (± SE) or numbers (%). Abbreviations: BMI, body mass index. DSI, dietary sodium intake. DKI, dietary potassium intake.
Table 5. OR of prevalent kidney stone according to DSI & DPI as continuous, categorical or binary variables in the multivariate regression model.
Table 5. OR of prevalent kidney stone according to DSI & DPI as continuous, categorical or binary variables in the multivariate regression model.
OR (95% CI) P Value
DSI
Continuous variable 0.99 (0.99-1.00) 0.2
Categorial variable Quartile 4 vs. 1 0.84 (0.68-1.04) 0.1
Quartile 3 vs. 1 1.05 (0.85-1.30) 0.6
Quartile 2 vs. 1 0.95 (0.79-1.10) 0.6
≤2300 mg vs. >2300 mg 1.10 (0.93-1.20) 0.3
DPI
Continuous variable 0.99 (0.99-0.99) 0.02
Categorial variable Quartile 4 vs. 1 0.75 (0.60-0.94) 0.01
Quartile 3 vs. 1 0.82 (0.67-1.01) 0.06
Quartile 2 vs. 1 0.82 (0.68-0.97) 0.02
>3500 mg vs. ≤ 3500 mg 0.87 (0.72-1.04) 0.1
DSI/DPI
Continuous variable 1.10 (1.01-1.20) 0.03
Categorial variable Quartile 4 vs. 1 1.30 (1.10-1.70) 0.008
Quartile 3 vs. 1 1.20 (0.99-1.40) 0.06
Quartile 2 vs. 1 1.20 (0.91-1.50) 0.2
>0.6 vs. ≤ 0.6 1.20 (0.86-1.67) 0.3
Abbreviations: DSI, dietary sodium intake. DKI, dietary potassium intake.
Table 6. Multivariate-adjusted OR of covariates from the model with dietary intakes as continuous variables.
Table 6. Multivariate-adjusted OR of covariates from the model with dietary intakes as continuous variables.
DSI DPI DSI/DPI
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P Value
Age (years) 1.02 (1.01-1.02) <0.001 1.02 (1.01-1.02) <0.001 1.02 (1.01-1.02) <0.001
Sex (Male) 1.20 (1.04-1.50) 0.02 1.30 (1.10-1.50) 0.005 1.2 (1.01-1.40) 0.03
Race (White) 2.30 (1.90-2.70) <0.001 2.30 (2.00-2.70) <0.001 2.3 (1.97-2.70) <0.001
BMI (>30 kg/m2) 1.70 (1.40-1.96) <0.001 1.60 (1.40-1.90 <0.001 1.6 (1.40-1.90) <0.001
History of hypertension 1.30 (1.04-1.50) 0.02 1.20 (1.03-1.50) 0.02 1.2 (1.03-1.50) 0.02
History of diabetes 1.50 (1.20-1.80) <0.001 1.50 (1.20-1.80) <0.001 1.5 (1.20-1.80) <0.001
History of dyslipidemia 1.20 (1.01-1.30 0.03 1.20 (1.01-1.30 0.03 1.2 (1.03-1.50) 0.03
Cardiovascular disease 1.20 (0.92-1.50) 0.2 1.1 (0.91-1.50) 0.3 1.2 (0.92-1.50) 0.2
Thiazide use 1.10 (0.86-1.30) 0.6 1.1 (0.85-1.30) 0.6 1.05 (0.85-1.30) 0.6
Smoking (active) 1.30 (1.10-1.50) 0.01 1.3 (1.04-1.50) 0.02 1.3 (1.10-1.50) 0.01
Alcohol (heavy) 0.49 (0.32-0.76) 0.002 0.51 (0.33-0.78) 0.002 0.5 (0.33-0.76) 0.002
DSI 0.99 (0.99-1.00) 0.2 N/A N/A N/A N/A
DPI N/A N/A 0.99 (0.99-0.99) 0.02 N/A N/A
DSI/DPI N/A N/A N/A N/A 1.1 (1.01-1.20) 0.03
N/A: not applicable. Abbreviations: BMI, body mass index. DSI, dietary sodium intake. DKI, dietary potassium intake.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2024 MDPI (Basel, Switzerland) unless otherwise stated